Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...

Booming sales of its blockbuster incretin-based weight loss and diabetes drugs Mounjaro and Zepbound powered Eli Lilly (LLY) to a 45% jump in ...

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

Fourth quarter revenues of $60.7 million, in line with previous guidanceFourth quarter GAAP net income of $2.2 million; non-GAAP net income of ...

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.

Weight loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss also comes with a loss of muscle mass and can lead to an increased risk of ...

Super Bowl advertising is a difficult assignment for marketers and agencies. Year after year, brands step onto the biggest ...

With the new year comes a brand-new age cohort – Generation Beta, the group of children that will take their first breaths from 2025 to 2039. And marketers are already planning accordingly.